| Literature DB >> 29791199 |
Asmaa A Al-Ekrish1, Wafa Alfaleh1, Romed Hörmann2, Ameera Alabdulwahid1, Wolfgang Puelacher3, Gerlig Widmann4.
Abstract
OBJECTIVES: To compare subjective and objective localization of the inferior alveolar canal (IAC) on multidetector CT (MDCT) images obtained by ultralow doses in combination with the reconstruction techniques of filtered backprojection (FBP), adaptive statistical iterative reconstruction (ASIR), or model-based iterative reconstruction (MBIR) as compared to standard dose MDCT and FBP.Entities:
Mesh:
Year: 2018 PMID: 29791199 PMCID: PMC6326396 DOI: 10.1259/dmfr.20170477
Source DB: PubMed Journal: Dentomaxillofac Radiol ISSN: 0250-832X Impact factor: 2.419
Figure 1. Reformatted panoramic sections of the mandibles used in the study obtained from the reference dose CT data sets. All the panoramic sections are 20 mm thick. Although the degree of cortication of the roof of the IACs is variable, the roof of the IAC is visible in all three mandibles bilaterally. IAC, inferioralveolar canal.
List of MDCT exposure parameters and reconstruction techniques used in the reference and low dose protocols
| Reference | FBP | 512 × 512 | 0.391 | 120 | 100 | 1.0 | 0.53 | 29.4 | 308.7 | 617.4 |
| LD1 | FBP | 512 × 512 | 0.391 | 100 | 35 | 0.5 | 0.53 | 4.19 | 44.0 | 88.0 |
| ASIR 50 | ||||||||||
| ASIR 100 | ||||||||||
| MBIR | 1024 × 1024 | 0.195 | ||||||||
| LD2 | FBP | 512 × 512 | 0.391 | 80 | 40 | 0.5 | 0.53 | 2.64 | 27.7 | 55.4 |
| ASIR 50 | ||||||||||
| ASIR 100 | ||||||||||
| MBIR | 1024 × 1024 | 0.195 | ||||||||
| LD3 | FBP | 512 × 512 | 0.391 | 80 | 15 | 0.5 | 0.53 | 0.99 | 10.4 | 20.8 |
| ASIR 50 | ||||||||||
| ASIR 100 | ||||||||||
| MBIR | 1024 × 1024 | 0.195 | ||||||||
| LD4 | FBP | 512 × 512 | 0.391 | 80 | 10 | 0.4 | 0.53 | 0.53 | 5.6 | 11.1 |
| ASIR 50 | ||||||||||
| ASIR 100 | ||||||||||
| MBIR | 1024 × 1024 | 0.195 | ||||||||
| LD5 | FBP | 512 × 512 | 0.391 | 80 | 10 | 0.4 | 0.97 | 0.29 | 3.0 | 6.1 |
| ASIR 50 | ||||||||||
| ASIR 100 | ||||||||||
| MBIR | 1024 × 1024 | 0.195 | ||||||||
ASIR, adaptive statistical iterative reconstruction; FBP, filtered back projection; LD, low dose protocol; MBIR, model-based iterative reconstruction.
Effective doses calculated based on a k-factor of 0.0021 for adult head examinations and tissue weighting factors from the International Commission on Radiologic Protection document ICRP 103 (2007).
Images of one sample site obtained with the reference dose protocol and the various combinations of test protocols and reconstructions techniques
ASIR, adaptive statistical iterative reconstruction; LD, low dose protocol; MBIR, model-based iterative reconstruction.
Figure 2. Sample site (transverse cross-sectional image of mandible) demonstrating the position and orientation and extent of the objective measurements. The measurement was recorded along the parasagittal reformatting line (open arrow head), and extended from the superior boundary of the ridge (arrow head) to inner surface of the roof of the IAC. If the parasagittal line did not pass through the roof of the IAC, the inferior extent of the measurement was determined by shifting the axial reformatting line until it contacted the inner surface of the roof of the IAC. The inferior extent of the measurement would then be determined as the point where the parasagittal line intersects with the axial line (arrow). IAC, inferior alveolar canal.
Sum of the scores of the subjective visibility of the roof of the inferior alveolar canal in images of the various protocols (n = 30 for all protocols)
| Reference dose | 107 | – | – | – |
| LD1 | 111 | 105 | 99 | 102 |
| LD2 | 96 | 108 | 115 | 99 |
| LD3 | 90 | 83 | 103 | 86 |
| LD4 | 68 | 73 | 84 | 80 |
| LD5 | 84 | 85 | 74 | 80 |
ASIR, adaptive statistical iterative reconstruction; FBP, filtered back projection; LD, low dose protocol; MBIR, model-based iterative reconstruction.
Differences between the linear measurements obtained by the reference protocol (reference dose/FBP) and the various test protocols
| LD1/FBP | 30 (100 %) | 0.05 | 0.781 | 0.98 | 0.41 | −0.31 | 0.176 |
| LD1/ASIR50 | 27 (90 %) | −0.04 | 0.771 | 0.65 | 0.22 | −0.30 | 0.094 |
| LD1/ASIR100 | 30 (100 %) | 0.10 | 0.349 | 0.56 | 0.30 | −0.11 | 0.743 |
| LD1/MBIR | 28 (93.3 %) | 0.01 | 0.953 | 0.63 | 0.25 | −0.24 | 0.960 |
| LD2/FBP | 30 (100 %) | 0.05 | 0.664 | 0.67 | 0.30 | −0.20 | 0.626 |
| LD2/ASIR50 | 27 (90 %) | −0.07 | 0.478 | 0.48 | 0.12 | −0.26 | 0.887 |
| LD2/ASIR100 | 28 (93.3 %) | −0.02 | 0.880 | 0.62 | 0.22 | −0.26 | 0.832 |
| LD2/MBIR | 29 (96.7 %) | −0.10 | 0.367 | 0.57 | 0.12 | −0.31 | 0.489 |
| LD3/FBP | 28 (93.3 %) | 0.41 | 0.029 | 0.94 | 0.78 | 0.05 | --- |
| LD3/ASIR50 | 23 (76.7 %) | 0.23 | 0.387 | 1.28 | 0.79 | −0.32 | 0.640 |
| LD3/ASIR100 | 26 (86.7 %) | −0.15 | 0.262 | 0.65 | 0.12 | −0.41 | 0.358 |
| LD3/MBIR | 28 (93.3 %) | −0.10 | 0.433 | 0.69 | 0.16 | −0.37 | 0.773 |
| LD4/FBP | 19 (63.3 %) | −0.28 | 0.230 | 0.98 | 0.19 | −0.75 | 0.420 |
| LD4/ASIR50 | 26 (86.7 %) | −0.28 | 0.079 | 0.79 | 0.04 | −0.60 | 0.694 |
| LD4/ASIR100 | 26 (86.7 %) | −0.37 | 0.002 | 0.55 | −0.14 | −0.59 | |
| LD4/MBIR | 24 (80 %) | −0.36 | 0.014 | 0.66 | −0.08 | −0.64 | |
| LD5/FBP | 26 (86.7 %) | 0.19 | 0.485 | 1.35 | 0.74 | −0.36 | 0.552 |
| LD5/ASIR50 | 28 (93.3 %) | 0.16 | 0.420 | 1.06 | 0.58 | −0.25 | 0.264 |
| LD5/ASIR100 | 29 (96.7 %) | 0.29 | 0.136 | 1.00 | 0.67 | −0.10 | 0.494 |
| LD5/MBIR | 22 (73.3 %) | 0.43 | 0.161 | 1.39 | 1.05 | −0.19 | 0.832 |
ASIR, adaptive statistical iterative reconstruction; FBP, filtered back projection; LD, low dose protocol; MBIR, model-based iterative reconstruction.
Statistically significant difference.
Bland–Altman Plot and linear regression not performed due to a significant difference detected in the one-sample t-test.